Arcturus Therapeutics Holdings (ARCT) EPS (Basic) (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) reported EPS (Basic) of -$0.95 for Q1 2026, down 82.69% on a YoY basis from -$5.49 in Q1 2025, and up 9.52% quarter-over-quarter from -$1.05 in Q4 2025.
Arcturus Therapeutics Holdings (ARCT) EPS (Basic) (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings has reported EPS (Basic) for 9 years, with the latest figure at -$0.95 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 82.69% year-over-year to -$0.95; the trailing twelve-month figure through Mar 2026 stood at -$2.83 (down 11.86% YoY), and the FY2025 full-year result was -$2.4, up 20.0% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.95, up from -$1.05 in the prior quarter.
- The five-year high for EPS (Basic) was $4.44 in Q4 2022, with the low at -$1.98 in Q2 2023.
- Historically, EPS (Basic) has averaged -$0.42 across 5 years, with a median of -$0.64 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 402.04% — and 2024, when it tumbled 152.36%.
- Arcturus Therapeutics Holdings' EPS (Basic) stood at $4.44 in 2022, then tumbled by 109.91% to -$0.44 in 2023, then plunged by 152.27% to -$1.11 in 2024, then gained by 5.41% to -$1.05 in 2025, then climbed by 9.52% to -$0.95 in 2026.
- The last three EPS (Basic) figures came in at -$0.95 (Q1 2026), -$1.05 (Q4 2025), and -$0.49 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | -0.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.95 |
| Dec 31, 2025 | -1.05 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | -1.11 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.64 |
| Mar 31, 2024 | -1.00 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -0.61 |
| Jun 30, 2023 | -1.98 |
| Mar 31, 2023 | 1.91 |
| Dec 31, 2022 | 4.44 |
| Sep 30, 2022 | -1.33 |
| Jun 30, 2022 | -0.82 |
| Mar 31, 2022 | -1.94 |
| Dec 31, 2021 | -1.47 |
| Sep 30, 2021 | -2.05 |
| Jun 30, 2021 | -2.07 |